‡a
Author's Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
‡a
identificationandcharacterizationofhivspecificresidentmemorycd8+tcellsinhumanlymphoidtissue
‡A
Identification and characterization of HIV-specific resident memory CD8 + T cells in human lymphoid tissue
‡9
1
‡a
safetypharmacokineticsandimmunologicalactivitiesofmultipleintravenousorsubcutaneousdosesofanantihivmonoclonalantibodyvrc01administeredtohivuninfectedadultsresultsofaphase1randomizedtrial
‡A
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
‡9
1
